The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Indirect mechanisms of action of a novel IgG1 monoclonal antibody, NEO-201, to enhance immune killing of tumor.
 
Philip M. Arlen
Employment - Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
Patents, Royalties, Other Intellectual Property - have patents held by Precision Biologics
 
Christina M. Annunziata
Research Funding - MaxCyte (Inst); Medivir (Inst); Precision Biologics (Inst)
Patents, Royalties, Other Intellectual Property - MaxCyte (Inst); Precision Biologics (Inst)
 
Massimo Fantini
Employment - Precision Biologics
Research Funding - Precision Biologics
Patents, Royalties, Other Intellectual Property - Precision Biologics
 
M. Pia Morelli
No Relationships to Disclose
 
Kwong Y. Tsang
Employment - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
Research Funding - Precision Biologics
Patents, Royalties, Other Intellectual Property - Precision Biologics